Aortic valve stenosis is a narrowing of the aortic valve opening that obstructs normal blood flow. The condition makes the heart work harder to push blood through a smaller than normal opening. As the narrowing worsens, it can become severe and life threatening. Studies show more than one in eight people age 75 and older have moderate or severe aortic stenosis, and the rate is likely to grow as the average life expectancy continues to increase.
Aortic stenosis is a very serious condition as people who have developed symptoms from severe aortic stenosis have about a 50% chance of living 2 years if they do not have an aortic valve replacement. Read more about aortic stenosis here.
The Jewish Hospital Heart Valve Team has developed a very successful transcatheter aortic valve replacement (TAVR) program and has performed more than any other hospital in the state and region. The team is the only hospital in Louisville to perform "awake" TAVR procedures, providing faster recovery times and less pain for patients with severe aortic stenosis. Regardless of your level of risk for standard valve replacement surgery, you might be a candidate for this minimally invasive procedure at Jewish Hospital.
Learn more about TAVR here.
Mitral regurgitation occurs when the mitral valve of the heart does not close tightly, resulting in the leakage of blood backward from the heart's left ventricle into the left atrium. Read more about mitral regurgitation here.
MitraClip was the world's first transcatheter mitral valve repair therapy, providing an option for select patients with mitral regurgitation. The MitraClip Delivery System consists of implant catheters and the MitraClip device. The device is a permanent implant that attaches to the mitral valve leaflets. This procedure results in a double opening of the mitral valve that improves closure and reduces the leakiness of the valve.